Genome editing software company Desktop Genetics and Imperial College London's cancer epigenetics unit have received a £300,000 ($430,000) grant from Innovate UK, which they will use to develop software tools that selectively design CRISPR/Cas9 targets against cancer cell lines that are characterized at the epigenetic level.
Portfolia launched the first ever Femtech focused investment fund in 2017, and has since invested in fertility company Future Family, vaginal health startup Madorra, genomics and diagnostics company Prime Genomics, which is developing a breakthrough approach to detect cancer, and the newest addition, Sana, an innovative device for pain management. Additionally, Portfolia has invested through others funds on menopause health platform Genneve and device company Joylux. Christina Jenkins, MD, is also an independent advisor to Elektra Health, a startup focusing on guiding women through menopause launching in 2020.
Cofactor is a large, structured listing of people, places, and things. Here you can find the description of each topic.